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3SUMMARY. The Saccharomyces cerevisiae GRX5 gene codes for a
mitochondrial glutaredoxin involved in the synthesis of iron/sulfur clusters. Its
absence prevents respiratory growth, and causes the accumulation of iron inside
cells and constitutive oxidation of proteins. Null Dgrx5 mutants were used as an
example of constitutively oxidized cells, as opposed to situations in which
oxidative stress is instantaneously caused by addition of external oxidants.
Whole transcriptome analysis was carried out in the mutant cells. The set of
genes whose expression was affected by the absence of Grx5 does not
significantly overlap with the set of genes affected in respiratory petite mutants.
Many Aft1-dependent genes involved in iron utilization that are upregulated in a
frataxin mutant were also upregulated in the absence of Grx5. BIO5 is another
Aft1-regulated gene induced both upon iron deprivation and in Dgrx5 cells; this
links iron and biotin metabolism. Other genes are specifically affected under the
oxidative conditions generated by the grx5 mutation. One of these is MLP1,
which codes for a homologue of the Slt2 kinase. Cells lacking MLP1 and GRX5
are hypersensitive to oxidative stress caused by external agents and exhibit
increased protein oxidation in relation to single mutants. This in turn points to a
role for Mlp1 in protection against oxidative stress. The genes of the Hap4
regulon, that are involved in respiratory metabolism, are downregulated in Dgrx5
cells. This effect is suppressed by HAP4 overexpression. Inhibition of respiratory
metabolism during constitutive moderately oxidative conditions could be a
protective response by the cell.   
4INTRODUCTION
Cells growing aerobically are subjected to oxidative stress caused by
reactive oxygen species (ROS)1 produced at the respiratory chain in the
presence of oxygen [1]. Cells have developed a number of enzymatic and non-
enzymatic mechanisms to counteract the damage that ROS cause to the different
cellular macromolecules. In the yeast Saccharomyces cerevisiae, addition of
external oxidants such as hydrogen peroxide or menadione (a generator of
superoxide anion) cause a rapid and generally transient transcriptional response
[2,3]. This consists of the induction of genes involved in hydrogen peroxide and
superoxide detoxification, as well as those related to redox homeostasis within
the cell. In the case of hydrogen peroxide, observations at the transcriptome level
confirm studies carried out at the proteome level [4,5]. Two transcriptional
regulators that respond to oxidative stress, Yap1 and Skn7, are important in such
a response to hydrogen peroxide [5,6]. The Yap1 regulon involves two types of
proteins: those required for antioxidant scavenging and enzymes that participate
in the metabolic pathways that regenerate cell reducing power in the form of
glutathione and NADPH. The first subset of proteins is also Skn7-dependent,
while the second is not [5]. Msn2 and Msn4 are two transcription factors that
respond to different stresses, including oxidative stress, by regulating gene
expression through binding to STRE promoter elements [7,8]. The defense
function of Msn2/4 partially overlaps with that of Yap1. However, Yap1 seems to
be more important for the adaptative response induced by moderate
concentrations of hydrogen peroxide, while Msn2/4 would be preferentially
implicated in recovery from acute exposure to the oxidant [9]. This is consistent
with the specific role that Msn2/4 has in regulating expression of genes involved
in protein degradation pathways [9].
5Most studies into the effect of oxidative stress on yeast cells have
involved adding external oxidants to cell cultures. However, this does not
necessarily reproduce the physiological effect caused by aerobic respiration or
other types of oxidation at moderate though constant levels. Proteins of S.
cerevisiae cells growing under aerobic conditions are more exposed to
constitutive oxidation than proteins from anaerobic cultures [10]. The latter
demonstrated permanent oxidative stress under the former conditions. However,
the gene expression pattern of cells that shift from fermentative to respiratory
metabolism at the diauxic transition [11,12] is very different from that of cells
subjected to external aggression by oxidants such as hydrogen peroxide,
menadione or diamide [2,3]. Thioredoxins and glutaredoxins are two thiol
oxidoreductases that play an important role in protecting sulphydryl groups in
proteins against oxidation, and therefore in maintaining the protein activity under
these conditions [13]. Grx5 is a monothiol glutaredoxin of S. cerevisiae (a single
cysteine at the active site) whose absence leads to high sensitivity to oxidative
agents and to constitutive carbonylation of proteins (a parameter that measures
protein oxidation [10]) even in the absence of external oxidative injury [14].
Accumulation of glutathionilated proteins has also been observed in the absence
of Grx5 [15,16]. This monothiol glutaredoxin is located at the mitochondria, where
it is involved in the formation of iron-sulfur clusters [17]. As occurs with other
proteins of the iron-sulfur assembly complex, lack of Grx5 causes iron
accumulation within the cell. This could be related to the observed constitutive
protein oxidation due to the formation of high levels of ROS via the Fenton
reaction [17]. A Dgrx5 mutant is therefore an appropriate model for studying the
effect of permanent oxidative stress on gene expression. In this work, we carried
out transcriptome analysis of the Grx5-defective mutant. The results show that
under these conditions the expression program was significantly different from
6the transcription pattern described in response to external oxidants, the inhibition
of respiratory genes being a relevant response.
EXPERIMENTAL PROCEDURES
Strains and Growth Conditions. Wild type S. cerevisiae strain W303-1A
(MATa ura3-52 leu2-3,112 trp1-1 his3-11,15 ade2-1) was employed in this study.
MML100 is a Dgrx5::kanMX4 derivative of W303-1A [17]. MML511 is an isogenic
derivative of W303-1A that contains the Dpet117::kanMX4 disruption. It was
constructed using the short-flanking homology approach following PCR-
amplification of the kanMX4 cassette (resistance for geneticin) from plasmid
pFA6a-kanMX4 with appropriate oligonucleotides [18]. The resulting PET117
deletion covers exactly from the initial to the stop codon. Disruption was
confirmed by PCR analysis [18]. The same strategy was employed for disruption
of YKL161c (MLP1) in the W303-1A background, although in this case the
natMX4 marker cassette (resistance for nourseothricin) was used [19]. The
resulting Dmlp1::natMX4 strain (MML524) was crossed with the
MATa  Dgrx5::kanMX4 mutant MML289 [17] and the double W303-1A
Dmlp1::natMX4 MATa  Dgrx5::kanMX4 mutant (MML533) was segregated. The
W303-1A aft1-D5::URA3 strain (MML348) has been previously described [17].
Plasmid pMT15 is a derivative of the multicopy vector pCM189 [20] that contains
HAP4 under the control of the doxycycline-regulated tetO7 promoter.
Cells were generally grown in rich YPD medium (1% yeast extract, 2%
peptone, 2% glucose) at 30ºC. In some experiments 3% glycerol was used
instead of glucose (YPGly medium). Synthetic complete medium (SC) contains
0.67% yeast nitrogen base (Difco), 2% glucose and the amino acids and nitrogen
7base additions indicated in Ref. 21. In some experiments, SC medium was
prepared by adding the individual components at the standard concentrations,
with the exception of biotin, which was included at the indicated final
concentrations.
Array Hybridizations and Data Analyses. Experiments representing a
particular situation were indepedently carried out in triplicate. Total RNA from
W303-1A wild type strain and the Dgrx5 and Dpet117 mutants was used to obtain
labelled cDNA. About 30-40 mg RNA were retrotranscribed into cDNA by adding
200 units of RT polymerase SuperScript II (Invitrogen), 500 ng of oligo dT primer
(5'-T15VN-3'), 1ml RNaseOUT (Invitrogen), 6 ml 5X First Strand Buffer (Invitrogen),
1.5 ml dNTP mix (16 mM dATP, dTTP, dGTP, and 100mM dCTP) and 5 ml 33P-
dCTP (10 mCi/ml) in a final reaction volume of 30 ml. Labelling reaction was
allowed for 1 h at 43ºC. One microlitre of EDTA 0.5 M was added to stop the
reaction. The labelled sample was purified using an S300-HR MicroSpin column
(Amersham BioSciences). After pre-hybridizing nylon membranes for 1 h in 5X
SSC, 5X Denhart's, 0.5% SDS, hybridizations were performed using the same
solution containing labelled cDNA (3.5 x 106 dpm/ml) for 16-18 h. After
hybridization, the filters were washed once in 2X SSC, 0.1 % SDS for 30 min,
and twice in 0.2 X SSC, 0.1 % SDS for 30 min. They were exposed to a imaging
plate (BAS-MP, Fujifilm) for 24 h and read in a Phosphorimager (FLA-3000,
Fujifilm) at 50 mm resolution.
The images were quantified by using ArrayVision 7.0 software (Imaging
Research, Inc.). Each mutant replicate was normalized against the corresponding
wild type hybridized in the same membrane (to eliminate the membrane
variability factor) following the Lowess method. Reproducibility of the replicates
was tested by the ArrayStat software (Imaging Research, Inc.). The data were
8considered as independent and the program was allowed to take a minimum of at
least two valid replicates in order to calculate mean and standard deviation
values for every gene. A Z-test for independent data was applied in order to
detect differences in individual gene expression between each mutant and the
wild type. Then, a Z-score was obtained for every gene.  A p-value of 0.05 and
the False Discovery Rate method were used to monitor the overall false positive
error rate.
Database Analyses. Data on the expression of individual genes from
global genome analyses were obtained from the Yeast Microarray Global Viewer
(yMGV, http://transcriptome.ens.fr/ymgv). Analysis of genes whose expression is
modulated throughout the cell cycle [22] was carried out with the Saccharomyces
Genome Database (http://genome-www.stanford.edu).
Northern Blot Studies. RNA electrophoresis, probe labelling with
digoxigenin, hybridization, and signal detection were carried out as previously
described [20]. Signals were quantified using the Lumi-Imager equipment
(Roche) software. Gene probes were generated from genomic DNA by PCR,
using oligonucleotides designed to amplify internal ORF regions.
Sensitivity Tests . Exponential cultures in YPD medium at 30ºC (about 2 x
107 cells per ml) were serially diluted (5-fold dilution factor), and two microlitre
drops of each dilution were spotted onto YPD plates containing inhibitory agents
at various concentrations. Growth was tested after three days of incubation at
30ºC. In parallel, growth was also recorded in YPD plates without an inhibitor
after incubation in the same conditions.
9Protein Carbonylation Analyses. Protein carbonyl groups in cell extracts
were derivatized with 2,4-dinitrophenilhydrazine. This was followed by SDS-
polyacrylamide gel electrophoresis and the immunodetection of peptides using
an anti-dinitrophenylhidrazone antibody, according to Ref. 10.
RESULTS
Wild type and isogenic Dgrx5 cells were grown exponentially in rich YPD
medium at 30ºC. Transcriptome analyses were carried out in three independent
experiments in these growth conditions for each of the strains. Table I lists the
genes that showed expression levels in Dgrx5 cells that were at least twice as
high as in wild type cells. Table II shows the genes whose expression levels in
Dgrx5 cells were at least 50% lower than the expression levels in wild type cells.
Cells lacking GRX5 exhibit a petite phenotype, that is, they do not grow under
respiratory conditions [17]. It has also been shown that S. cerevisiae
mitochondrial DNA rhoº mutants have an altered expression profile [23]. As
expression pattern for Dgrx5 cells could have been influenced by their petite
defects, we carried out a parallel transcriptome analysis of Dpet117 cells with the
same W303-1A genetic background. The total number of genes either up or
downregulated in the Dgrx5 mutant was considerably lower than in the Dpet117
cells (Fig. 1A). Both Table I and II indicate the genes affected in Dgrx5 cells that
were respectively up or downregulated in Dpet117 with respect to wild type cells.
The proportion of these genes was very low in both cases, and we can therefore
conclude that the transcriptome profile of Grx5-deficient cells was not significantly
influenced by the petite character of the mutant. As revealed by FACS analysis2,
                                                                
2 M. A. de la Torre, G. Bellí and E. Herrero, unpublished data
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the Dgrx5 mutant accumulated a large proportion of cells at the G1 stage of the
cell cycle. This fact could have influenced the expression profile of those genes
whose expression changed throughout the cell cycle [22]. However, the
proportion of these cell cycle-dependent genes whose expression is up or
downregulated in the Dgrx5 cells was low (Tables I and II), and overall, this did
not significantly affect the analyses.
Overexpressed Genes in Dgrx5 Cells. A total of 99 genes showed at least
two-fold induction of expression in cells lacking Grx5 as opposed to wild type
cells (Table I). For some of these genes, the results were confirmed by Northern
analysis (Fig. 2A). A group of genes implicated in ion homeostasis, especially in
iron and copper transport, was induced in Dgrx5 cells. Most of these genes were
controlled by the transcriptional activator Aft1, which responds to iron deprivation
by inducing the expression of genes coding for plasma membrane
metalloreductases (FRE1-3), the multicopper ferroxidase (FET3), the iron
permease (FTR1), copper ion transporters (ATX1, CCC2), components of the
siderophore-iron uptake system (ARN1-4), cell wall-associeted facillitators of iron
uptake (FIT1-3), and heme oxygenase (HMX1) [24-29]. Most of these genes are
also upregulated in a yeast Dyfh1 mutant, which lacks the yeast homologue of
human frataxin [27]. Absence of frataxin causes mitochondrial accumulation of
iron in a form that is not available to the cells [30], and this probably signals the
activation of Aft1 [27]. We had previously shown that disruption of iron-sulfur
cluster assembly through Grx5 inactivation also caused iron accumulation [17],
and the results presented in Table I support the idea that this iron pool is also in a
form that is not available to the cell.
Two genes associated to biotin transport were upregulated in Grx5-
deficient cells, VTH1 and BIO5. VTH1 has been characterized as coding for a
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plasma membrane high-affinity biotin transporter, and its expression is repressed
in media with high biotin levels [31]. It has recently been reported that this gene is
an Aft1 target [29]. This suggests that its upregulation in Dgrx5 cells could also be
a consequence of iron deficiency in these cells. More intriguing is the
upregulation of the BIO5 gene (Table I and Fig. 2A). S. cerevisiae cells require
an external source of biotin as they lack the first enzyme of the pathway that
converts pimelic acid into biotin [32]. However, they are able to grow on the biotin
vitamers 7-keto 8-aminoperlargonic acid (KAPA), 7,8-diamino-pelargonic acid
and dethiobiotin, which are sequential intermediates in the pathway that leads to
biotin [32]. The last enzyme in the pathway (biotin synthase) converts dethiobiotin
into biotin and is the product of BIO2 in S. cerevisiae. This enzyme contains
iron/sulfur centers [33,34] and its activity therefore would be very low in Dgrx5
cells.  We have observed that Dgrx5 cell growth was no more dependent on
biotin concentration in the SD medium (from 20 to 0.1 mg/liter) than growth of
wild type cells under the same conditions (Fig. 2B). This would seem to
dissociate the absence of an active Bio2 protein from the biotin requirement. The
BIO5 product has been characterized as the transporter of KAPA, which is a
vitamer that is probably not present in either natural or laboratory yeast cell
growth media [32]. We examined whether BIO5 expression was also dependent
on biotin levels in the growth medium, as in the case of VTH1. However, this was
not the case (Fig. 2C). On the other hand, BIO5 expression was upregulated
upon iron chelation by ferrozine, similarly to the well known Aft1-dependent gene
FET3 (Fig. 2D). This upregulation did not occur in a null aft1 mutant (Fig. 2D),
which showed that BIO5 must be a member of the Aft1 regulon. Altogether, these
results confirm the previous suggestion [29] that biotin synthesis and transport
are related to iron metabolism in yeast cells.
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SNZ1 transcription was increased in Dgrx5 cells (Table I and Fig. 2A).
This gene is involved in vitamine B6 (piridoxine) biosynthesis and has orthologues
in various prokaryotes and eukaryotes [35]. Its upregulation in the absence of
Grx5 (from almost undetectable levels in wild type cells) could be related to the
proposed effect of piridoxine as a quencher of singlet oxygen  [36]. This
hypothesis is supported by the fact that yeast snz mutants are hypersensitive to
the singlet oxygen generator methylene blue [37].
YKL161C (MLP1) is one of the genes that showed highest relative
induction-fold in Dgrx5 cells (Table I). The Mlp1 protein is homologous to the Slt2
(Mpk1) MAP kinase, although it lacks the conserved active site of MAP kinases
[38]. Overexpression of MLP1 suppresses the caffeine-sensitivity phenotype of a
bck1 mutant in the signal transduction pathway leading to Slt2, while a null mlp1
mutant has additive effects on caffeine sensitivity when combined with a slt2
mutation [38]. However, a single null mlp1 mutant does not show apparent
phenotype. These observations suggest that Mlp1 acts in a pathway parallel to
the Slt2 pathway in the regulation of downstream targets involved in cell integrity
such as Rlm1 [39]. On the basis that the grx5 mutant overexpresses MLP1, we
reasoned that the absence of the latter could enhance defects in cells lacking
GRX5. The double Dgrx5 Dmlp1 mutant (strain MML533) was no more sensitive
to caffeine, to the cell wall inhibitor calcofluor white or to heat shock (growth at
38ºC) than either the single Dmlp1 mutant or the wild type cells (not shown). The
latter are phenotypic defects characteristic of cells where the Slt2 MAP kinase
pathway is affected. However, the double mutant was more sensitive than the
single Dgrx5 mutant to t-BOOH and menadione (Fig. 3A). The MLP1 function
could therefore play a protective role against oxidative stress in Dgrx5 cells.
Importantly, hypersensitivity to external oxidants was not observed in the single
Dmlp1 mutant (Fig. 3A). We then tried to correlate sensitivity to oxidants with
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protein oxidation for the different genetic backgrounds. Carbonylation of protein
residues (see Experimental Procedures for determination) was used as a
measure of protein oxidation [10,14]. As expected from previous studies [14],
under normal growth conditions Dgrx5 cells contained more carbonyl groups in
proteins than wild type cells. In contrast, Dmlp1 cells exhibited even fewer
carbonyl groups in total protein extracts than wild type cells (Fig. 3B). Protein
carbonylation in the double Dgrx5 Dmlp1 mutant was slightly higher than in the
single Dgrx5 mutant (Fig. 3B). When total carbonyl groups were quantified
[10,14], the doble mutant consistently gave values about 30% higher than Dgrx5
cells. These differences were much larger after treatment with t-BOOH: under
these conditions we observed an additive effect between the two mutations on
protein carbonyl content (Fig. 3B). It is also interesting that protein oxidation in
the treated single Dmlp1 mutant was greater than in wild type cells, though less
than in Dgrx5 treated cells. Altogether these results support the protective role of
MLP1 against external oxidants, particularly when the Grx5 function is absent.
Genes of the Yap1 and Msn2/4 Regulons were not Constitutively Induced
in the Absence of Grx5. In yeast, oxidative stress by external agents such as
hydrogen peroxide, menadione or diamide causes upregulation of genes involved
in glutathione and thioredoxin-based defence and repair systems against
oxidative damage, and also of other antioxidants such as superoxide dismutases
and catalases (see Ref. 6 for details). This induction is regulated by one or
several of the transcriptional factors Msn2/4, Yap1 and Skn7. None of the above
genes appeared to be upregulated in the experiments shown in Table I for Dgrx5
cells. We confirmed these results by Northern blot analysis for a number of genes
that are known to be upregulated by external oxidants: DDR2 [40], GSH1 [41],
HSP12 [42], CTT1 [40], TRX2 [43] and TRR1 [5]. Basal expression in Dgrx5 cells
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did not differ significantly from wild type cells in any of these cases (Fig. 4A).
However, the Yap1 and Msn2/4 regulatory systems remained functional in the
mutant, since GSH1 (whose induction by oxidants is Yap1-dependent [5,41]) and
DDR2 (Msn2/4-dependent [7, our unpublished observations]) were inducible by
hydrogen peroxide in wild type and Dgrx5 cells (Fig. 4B).
Repressed Genes in Dgrx5 Cells. A total of 64 genes had an expression
level in Dgrx5 cells that was 50% or less with respect to wild type cells (Table II).
Thirty-four of these genes were also downregulated by external oxidants, as
shown in Ref. 2 and 3. This confirmed that the Dgrx5 cells were subjected to
metabolic oxidative stress. However, the remaining 30 genes in Table I were
specifically downregulated in the mutant. These included the YFH1 frataxin gene.
Decreased expression of the latter was confirmed by Northern blot analysis (Fig.
2A). Twenty of the downregulated genes were nuclear genes involved in
mitochondrial functions, mostly in respiration (Table II). We confirmed the
downregulation of CYC1 and COX13 by Northern blot analysis (Fig. 2A). It has
been reported that petite cells display decreased expression of a number of
genes related to mitochondria [23]. However, none of the genes reported in that
study were among the genes downregulated in the present work. Only three of
the mitochondrial genes in Table II (CYC1, COX5A and COX17) displayed
decreased expression in the Dpet117 mutant. We therefore concluded that for
most of these mitochondrial function genes the decreased expression is specific
to the null grx5 mutant. It can be deduced that this is a specific response of
genes involved in respiration and other mitochondrial energy metabolism
functions caused by the constitutive generation of ROS in Grx5-deficient cells.
Hap4 is a transcriptional factor that upregulates S. cerevisiae respiratory
functions and that is therefore important in the shift from fermentative to
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respiratory metabolism which occurs at the diauxic shift [12,44]. We analyzed
previous reports [11,12] to determine whether there were any changes in the
expression pattern of mitochondrial function genes downregulated in Dgrx5 cells
during the diauxic shift [11] or after overexpression of Hap4 [12]. In fact, the
expression of 14 of these genes is upregulated after the diauxic shift and/or by
Hap4 overexpression (Table III). Two of the unknown function open reading
frames (YDR316w and YER182w) showing strong downregulation in Dgrx5 cells
(Table II) are also Hap4-dependent [12].
We studied the expression of one of these genes, CYC1, in conditions in
which HAP4 was overexpressed in order to demonstrate that downregulation of
Hap4-dependent genes in cells deficient in Grx5 was not indirect. As expected
from previous studies [45], overexpressing HAP4 in wild type cells led to an
increased expression of CYC1 (Fig. 5A). Under the same conditions, Dgrx5 cells
expressed CYC1 at almost the same level (only 20% reduction) as the wild type
cells, contrasting significantly with the situation in non-overexpression conditions
(which experienced a three-fold reduction) (Fig. 5A). This confirmed that the
observed downregulation of Hap4-dependent genes occurred as a direct
consequence of the absence of Grx5.
Based on the hypothesis that downregulation of respiratory genes is a
response to the constitutive oxidation of cell molecules which occurs in the
absence of Grx5, it would be expected that a shift to respiratory metabolism by
HAP4 overexpression would have a negative effect on the physiology of Dgrx5
cells. Although these cells have no functional respiratory chains due to defects in
iron-sulfur cluster biogenesis [17], ROS could still be produced as a consequence
of incomplete electron transfer. The overexpression of HAP4 caused increased
carbonylation of cell proteins even in a wild type background, although this effect
was higher in Dgrx5 cells (Fig. 5B). This confirmed that respiratory conditions are
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a source of ROS able to cause oxidative damage on proteins, and also that there
are additive effects between the absence of Grx5 activity and the increased
expression of respiratory genes. In accordance with these observations,
overexpression of HAP4 in the Dgrx5 mutant significantly lowered growth rate
compared to mutant cells displaying normal levels of HAP4 expression. In
contrast, this effect of HAP4 overexpression on cell growth was not observed in
wild type cells (Fig. 5C). Altogether, these observations support the biological
significance of the observed downregulation of respiratory genes in the absence
of Grx5.
DISCUSSION
In this work we used a Grx5-deficient mutant as a model for yeast cells
constitutively subjected to moderate oxidative stress, in order to study the genes
whose expression was significantly modified under these conditions. As the
Dgrx5 mutant exhibits a petite phenotype [17], we had to first distinguish between
the genes whose modified expression was specifically due to the petite character
of the cells and those genes affected by other physiological effects of the grx5
mutation. Very few of the genes affected in the Dpet117 mutant were also
affected in the Dgrx5 mutant cells (Tables I and II). Furthemore, there was no
overlap with the genes shown to be differentially expressed in rhoº cells in a
previous study [23]. Therefore, most of the expression changes seen in Dgrx5
cells do not seem to be due to the respiratory deficiencies in these cells. It is also
interesting that a small set of genes displayed significantly altered expression in
opposite ways when both mutants were compared (Fig. 1B). Most of the twelve
genes that were upregulated in Dgrx5 cells and downregulated in the petite
mutant are of unknown function, although the group also included two genes
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(FIT3 and ARN2) related to iron uptake. Of the sixteen genes upregulated in the
Dpet117 mutant and downregulated in the Dgrx5 cells, four (ILV3, LYS4, BAT1
and GAP1) are involved in amino acid metabolism and transport. This could be
related to the fact that up to thirty two genes involved in amino acid metabolism
and transport were induced in the Dpet117 mutant. This is a situation that
extends to genes for purine and pirimidine biosynthesis (data not shown in
detail). The upregulation of genes in these functional categories was not
observed in rhoº cells [23].
A subset of the genes upregulated in the absence of Grx5 is also
upregulated in the frataxin yfh1 mutant [27]. These genes are regulated by the
transcriptional activator Aft1. The latter responds to iron deprivation by regulating
its nuclear localization and activating genes that participate in iron and copper
utilization [24-29, 46]. In this study we added BIO5 to the list of genes that are
regulated by Aft1 in a way that is dependent on iron concentration in the medium.
This confirmed the previously reported relationship between biotin metabolism
and iron assimilation [29]. The upregulation of Aft1-dependent genes in the yeast
frataxin mutant was taken as evidence that the iron accumulating in the
mitochondria of the mutant cells is in a non-metabolizable form, and that yfh1
cells are therefore nutritionally depleted of iron [27]. Similarly, iron accumulates
intracellularly at abnormally high levels in the Dgrx5 mutant [17], probably as a
consequence of the disruption of the Grx5 function in the iron-sulfur cluster
assembly. The results shown here suggest that the accumulated iron in the grx5
cells is not available for cell metabolism. There is, however, an alternative
explanation, which is based on the fact that the YFH1 gene was downregulated
in cells lacking Grx5 (Table I and Fig. 2A). This could make the Dgrx5 cells
phenotipically similar to a Dyfh1 mutant. In this case, iron accumulation in the
Dgrx5 mutant would not be a direct consequence of disruption of iron-sulfur
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cluster assembly, but secondary to depletion of Yfh1 molecules. We, however,
favour the first alternative, since iron accumulation is common to many mutants in
genes involved in the assembly of iron-sulfur clusters [47]. At this respect, recent
studies indicate that the primary function of yeast frataxin is the synthesis of iron-
sulfur clusters [48-50] and heme groups [51]. In order to carry out this function,
Yfh1 would act as an iron chaperone and an iron store to provide Fe(II) [52] to
the assembly complexes.
Two genes that could be related to protection against the oxidative stress
generated in these conditions were upregulated in the absence of Grx5. One of
these is SNZ1, through its role in the biosynthesis of piridoxine [35], a vitamin
that acts as a protector against single oxygen [36]. The second is MLP1, which
codes for a homologue of the Slt2 MAP kinase [38]. Slt2 plays a central role in
the S. cerevisiae cell integrity pathway by activating at least two transcriptional
factors: Rlm1 and SBF [53]. These factors respond to stimuli that alter the
integrity of the cell envelope by respectively activating the expression of cell wall
biosynthesis genes and cell cycle genes [54,55]. However, genes that protect
against oxidants do not appear to be targets of Rlm1 or SBF. Genetic interactions
between SLT2 and MLP1 suggest the existence of some parallel functions
between the two gene products [38], but the hypothetical targets for the Mlp1
function are unknown. Our results showed additivity between the Dgrx5 and
Dmlp1 mutants in their sensitivity to oxidants and in their levels of both
constitutive and oxidant-induced protein carbonylation. This supports a functional
relationship between Grx5 and Mlp1. The single Dmlp1 mutant was no more
sensitive to oxidative stress than wild type cells. Therefore, the Mlp1 hypothetical
protective role against oxidative stress was only manifested under the
constitutive stress conditions occurring in the absence of the Grx5 function.
Transcriptome analysis of the mlp1 mutant and of cells overexpressing MLP1
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could help to reveal more details about the role of Mlp1 relative to oxidative
stress.
On the other hand, Msn2/4, Yap1 and Skn7 regulon genes were not
constitutively upregulated in Dgrx5 cells. This indicates that either the stress
signal generated in the glutaredoxin mutant was not sufficient to activate the
respective transcriptional activators, or that these were in fact only acting in
response to instantaneously generated external signals and not to a sustained
stress signal.
A significant number of genes whose expression was downregulated in
the Dgrx5 background are Hap4-regulated. Hap4 is the activator component of a
complex in which the Hap1/2/3/5 proteins also participate. These are necessary
for binding of the complex to specific promoter sites. The Hap complex is
required for expression of respiratory genes [56]. Overexpression of Hap4 is
sufficient to cause the shift from fermentative to respirarory metabolism, through
induced expression of respiratory genes [12,45]. We have shown in the present
work that overexpression of HAP4 suppresses the downregulation of the Hap4-
dependent gene CYC1 in Dgrx5 cells. This supports the idea that expression of
the respiratory genes is repressed in the mutant cells through the inhibition of
Hap4 activity. Heme could initially be proposed as the mediator involved in the
process. In fact, it is required for the activation of Hap4-dependent genes [29,56].
In Dgrx5 cells, depletion of metabolically available iron and consequent
upregulation of the heme oxygenase gene HMX1 [29] leads to heme depletion
and eventually to Hap4 inactivation. However, the downregulation of this set of
genes is not observed in yeast cells that lack the Yfh1 frataxin, in which non-
available iron also accumulates and HMX1 is also repressed [27]. The specificity
of the response in cells without Grx5 therefore points to additional factors being
20
responsible for regulating Hap4 activity under conditions of moderate constitutive
oxidative stress.
Based on the role of Grx5 in the biogenesis of iron-sulfur clusters, the
respiratory deficiency of Dgrx5 cells [17] could be initially explained by the
absence of Rip1 activity. Rip1 is the iron-sulfur Rieske protein that is part of
complex III in the yeast respiratory chain [57]. S. cerevisiae cells have not
respiratory complex I, which in mammalian cells also contains iron-sulfur
proteins. In yeast, complex I is replaced by the mitochondrial inner membrane
Ndi1 NADH-dehydrogenase [58,59]. In mammalian cells, both complex I and
complex III are sources of ROS, whose production is enhanced by cytochrome
oxidase inhibition [60,61]. It can therefore be hypothesized that incomplete
respiratory chains in Grx5-deficient cells are sources of ROS with sustrates such
as NADH or succinate, unless all chain components are depleted, for instance
through Hap4 inhibition. The situation observed in cells lacking Grx5, in which
expression of  the different components of the respiratory chain (including the
NDI1 gene) was inhibited, could be extrapolated to other situations in which
ROS-mediated stress exists. This could be a general response to prevent
respiratory production of ROS. Other models for metabolically-generated
constitutive oxidative stress need to be tested to confirm this hypothesis.
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LEGENDS TO THE FIGURES
FIG. 1. Comparative expression of S. cerevisiae genes in Dgrx5 and Dpet117
cells. A, expression of each individual gene (marked by a square) in Dgrx5 cells
(MML100) in relation to its expression in Dpet117 cells. Values result from
normalizing the expression level of the gene in the respective mutant by its
expression in wild type cells (log2 of the ratio). B, genes whose relative
expression was significantly modified in divergent ways in Dgrx5 and Dpet117
mutants. Only induction and repression ratios (mutant vs. wild type) of two or
more were considered significant.
FIG. 2. Representative genes differentially expressed in wild type and Dgrx5
cells. A, Northern blot analysis of some of the genes that were induced (Table I)
or repressed (Table II) in the Dgrx5 mutant (strain MML100) relative to wild type
cells (W303-1A). The snU2 mRNA served as a loading control, and ACT1 is
representative of genes whose expression did not vary in the mutant. Samples
were taken from exponential cultures in YPD medium at 30ºC. B, Growth levels
(measured by optical density units at 600 nm) of wild type cells (solid bars) and
Dgrx5 mutant cells (open bars) after two days at 30ºC in liquid SC medium with
biotin at the indicated final concentrations. Initial inocula contained 105 cells per
ml. Growth levels in cultures of both strains containing biotin at 20 mg per litre
were respectively given unit value. C, Northern blot analysis of BIO5 expression
in exponential cultures of wild type and Dgrx5 cells in SC medium at 30ºC, with
biotin at the indicated concentrations. D, Northern blot analysis of FET3 and
BIO5 expression in wild type (W303-1A) and aft1-D5 (MML348) cells. Samples
were obtained from exponential cultures in YPD medium at 30ºC; ferrozine was
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added at 2 mM final concentration at time 0. Same amounts of RNA were loaded
per lane, as determined by snU2 mRNA analysis (not shown).
FIG. 3. Sensitivity of null mutants in the GRX5 and MLP1 genes to oxidative
stress. A, wild type (W303-1A), Dgrx5 (MML100), Dmlp1 (MML524) and Dgrx5
Dmlp1 (MML533) cells were tested for sensitivity to t-BOOH or menadione, on
YPD plates containing the oxidative agent at the indicated concentration. B,
protein oxidative damage in the indicated strains, as measured by the presence
of side carbonyl groups. Total protein extracts were obtained from untreated or t-
BOOH-treated cultures, and analyzed by Western blot (20 mg of total protein per
lane) using antibodies against anti-2,4-dinitrophenylhidrazones [10].
FIG. 4.  Expression of oxidative stress-inducible genes in a Dgrx5 genetic
background. A, Northern blot analysis of the indicated genes in exponentially-
growing wild type (W303-1A) and Dgrx5 (MML100) cells in YPD medium. SnU1
mRNA was included as a loading control. B, Induction of DDR2 and GSH1
expression by menadione (Md) at the indicated concentrations, in wild type and
Dgrx5 cells growing exponentially in YPD medium. The expression of a non-
inducible gene (ACT1) is also shown.
FIG. 5. Effect of HAP4 overexpression in wild type and Dgrx5 cells. Wild type
(W303-1A) and Dgrx5 (MML100) cells were transformed with plasmid pMT15
(that overexpresses HAP4 under the tet promoter). Non-transformed and pMT15-
transformed cells were grown in liquid SC medium at 30ºC. Samples were taken
in exponential conditions. A, Northern blot analysis of HAP4 and CYC1
expression. SnU2 mRNA is shown as a loading control. B, carbonyl groups in
total cell proteins, after Western blot analysis (20 mg of total protein per lane).  C,
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growth rates of the respectives cultures (mean of three experiments). Values over
bars indicate the optical density (at 600 nm) doubling times in minutes, in
exponential growth conditions.  
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Table I
Genes induced in Dgrx5 cells
Values are averages for three independent experiments
Induction Aft1-
Gene fold Function/characteristics Dyfh1ª dependentb Cell cyclec
Ion homeostasis
FIT3 52.2 Siderochrome transport + + M
ARN2 10.4 Siderochrome transport + +
FRE3 10.2 Ferric chelate reductase + +
FIT1 7.9 Siderochrome transport + +
ARN1 7.3 Siderochrome transport + +
FIT2 6.0 Siderochrome transport + +
FTR1* 5.4 Iron ion transport + + M
SIT1 3.8 Siderophore transport + + M
PCA1 3.2 Cooper ion homeostasis
FTH1 3.0 Ftr1 homologue + +
HMX1 2.9 Heme oxygenase, iron homeostasis + +
CCC2 2.8 Copper ion transport + +
CTR2 2.3 Cooper ion transport +
ATX2 2.2 Manganese ion homeostasis +
CUP1-1 2.1 Cooper ion binding
Transport
MUP3* 8.1 Methionine permease +
AUS1 4.1 Sterol transport
VHT1 3.4 Biotin transporter + M
HXT2 2.1 Hexose transporter
Biosynthesis
BIO5 7.3 Biotin biosynthesis +
SNZ1 3.0 Vitamin B6 biosynthesis
THI21 2.9 Thiamine biosynthesis
NCP1 2.7 NADP-cytochrome P450 reductase,
ergosterol biosynthesis
ADE16 2.2 Purine biosynthesis
CYS3 2.2 Cysteine biosynthesis
Carbon and lipid catabolism
AMS1 3.5 Vacuolar alpha-manosidase
IDH2 2.5 Isocitrate dehydrogenase subunit II
IDH1 2.4 Isocitrate dehydrogenase subunit I M
OLE1 2.3 Stearoyl-CoA desaturase M/G1
PDA1 2.2 Piruvate dehydrogenase
Mitochondrial biogenesis and functions
MRS4 3.4 Mitochondrial carrier protein
ISU1 3.3 Iron-sulphur cluster assembly + +
MMT2 2.2 Mitochondrial iron transport
Protein targeting
AKR1 2.6 Palmotoyltransferase, endocitosis +
PMT3 2.2 Dolichyl-phosphate-mannose protein G1
mannosyltransferase
SEC61 2.2 Protein transporter
STV1 2.2 Hydrogen-transporting ATPase, Golgi
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apparatus
Protein degradation
LAP4 3.0 Aminopeptidase I + G1
UBC8 2.4 Ubiquitin conjugating enzyme
PRE2 2.4 Proteasome endopeptidase
PRB1 2.3 Serine-type endopeptidase + S
Stress responses
HSP26 8.5 Heat shock protein S
SLT2 2.1 PKC-dependent MAP quinase
Cell wall
TIR3 8.3 Mannoprotein, cold shock-induced M
TIR1 6.4 Mannoprotein, cold shock-induced
TIR2 3.2 Mannoprotein, cold shock-induced
GSC2 2.8 Beta-1,3 glucan biosynthesis
Others
APG16* 14.8 Autophagy
ENT4 2.7 Cytoskeletal adaptor
Unknown function
DAN1 15.0 Induced under anaerobic conditions
YKL161C 11.0 Strong similarity to Slt2
PAU7 8.7 Member of the seripauperin protein/
gene family
YHL035C 7.4
YDR476C 7.0
YOL161C 6.9
YPL272C 5.9
LSB3* 5.4
YPR076W* 5.4
YMR325W 5.3
PRY1 5.2 M
YGL039W 5.2 Dihydrokaempferol 4-reductase
PAU1 5.1 Member of the seripauperin protein/
gene family
TIS11 5.1 + +
PAU3 4.9 Member of the seripauperin protein/
gene family
YBR047W 4.9
PAU6 4.7 Member of the seripauperin protein/
gene family
YIR041W 4.5
PAU2 4.4 Member of the seripauperin protein/
gene family
YPR039W* 4.3
YFR024C 4.2
YGR294W 4.1
YGL261C 4.0
PAU5 3.8 Member of the seripauperin protein/
gene family
YHL046C 3.7
YKR104W 3.6
NFT1 3.6 Putative ABC transporter
YOR394W 3.6
YNL190W 3.6
YIL176C 3.6
YGR160W 3.4
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YKL162C* 3.3
YDR271C 3.2
YLL064C 3.2
YDR319C 3.1
YOL087C 3.0
PRM4 3.0 Pheromone-regulated membrane
protein
YMR041C 2.7
YHR199C 2.6
YOR389W 2.4
YGR160W 2.4
YOR385W 2.3
YNL208W 2.3
YCL027C 2.2
YPL278C 2.1
YPR090W 2.1
NOG1 2.1 Nucleolar GTPase
YKL224C 2.0
DAN3 2.0 Putative cell wall protein
SNA3 2.0
ª Genes upregulated in a Dyfh1 mutant [27] are marked with a + sign
b Genes whose expression is Aft1-dependent are marked with a + sign
c For genes with a cell cycle-dependent expression [22], the stage with the greatest
expression is indicated
Asterisks indicate genes upregulated in a Dpet117-defective mutant.
Genes in boldface type were not induced by hydrogen peroxide, menadione or diamide
treatment in experiments reported in Ref. 2 and 3. Induction was considered to exist only
when at least two consecutive time points gave significantly increased levels under the
experimental conditions employed in these studies
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Table II
Genes repressed in Dgrx5 cells
Values are averages for three independent experiments
Gene Change Function/characteristics Cell cycleb
Ion homeostasis
YFH1 3.3 Frataxin, iron homeostasis
CCC1 3.3 Fe, Ca and Mn ion homeostasis
Biosynthesis
CYB5 7.7 Sterol biosynthesis M
GLT1 7.4 Glutamate synthase
ILV3 4.7 Isoleucine and valine biosynthesis
DPH2 3.2 Diphtamide biosynthesis
LYS4 2.6 Lysine biosynthesis
ERG11 2.0 Sterol metabolism
Carbon and lipid catabolism
DLD1 2.8 D-lactate dehydrogenase
PDC5 2.1 Pyruvate decarboxylase
Mitochondrial biogenesis and functions
MEF2 25.0 Mitochondrial translation elongation factor
CYC1ª* 9.6 Cytochrome c isoform 1
CYT1 7.0 Electron transporter G2
QCR10 6.7 Ubiquinol-cytochrome c oxidoreductase subunit
MHR1 6.2 Mitochondrial transcription regulator
RIP1 5.9 Ubiquinol-cytochrome c reductase
COX7 5.7 Cytochrome c oxidase subunit
QCR8 5.0 Ubiquinol-cytochrome c oxidoreductase subunit
NDI1 4.2 NADH dehydrogenase M
COX6 3.8 Cytochrome c oxidase subunit
SDH4 3.3 Succinate dehydrogenase
QCR7 3.7 Ubiquinol-cytochrome c oxidoreductase subunit
QCR6 3.1 Ubiquinol-cytochrome c oxidoreductase subunit
COX5Aª 3.1 Cytochrome c oxidase subunit
QCR9 2.9 Ubiquinol-cytochrome c oxidoreductase subunit
COX13 2.7 Cytochrome c oxidase subunit
COX12 2.6 Cytochrome c oxidase subunit
COX9 2.5 Cytochrome c oxidase subunit
OAC1 2.4 Oxalacetate carrier activity
COX17* 2.3 Cytochrome c oxidase assembly
Cell cycle and mating
AGA2 3.5 a-agglutinin subunit M/G1
APC5 3.4 Subunit of anaphase-promoting complex
MAD1* 2.9 Mitotic spindle checkpoint
TEC1 2.8 Transcription factor involved inM/G1
pseudohyphal growth
BAR1 2.6 alpha-factor protease
BUB1 2.6 Mitotic spindle checkpoint G1
MOB2 2.4 Establishment of cell polarity
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Stress responses
GRX4 4.8 Glutaredoxin, oxidative stress response
PHO5 3.0 Acid phosphatase, response toM
phosphate starvation
Others
PDR15* 3.4 ABC transporter involved in multudrug resistance
MLP2* 3.4 Nuclear protein targeting
CWP2 3.1 Cell wall organization G2
PHO3 2.6 Acid phosphatase, thiamine uptake M
BAT1 2.6 Branched chain amino acid degradation G2
GAP1 2.4 General amino acid transport
PHO12 2.1 Acid phosphatase
Unknown function
YDR316W* 4.2
YER182W* 3.8
YER156Cª* 3.7
YJL200C 3.1
KRR1* 3.0
CTH1 3.0
YEL033W 2.9
YJL018W 2.9
YMR102c* 2.9
ABM1 2.8
YAL046C 2.7
YNL144C* 2.7
YPL146C* 2.7
YBR028C 2.6
YLR198C 2.5
YOL109W 2.5
YHR045W 2.4
YBR025C 2.1
ª Genes also repressed in a Dyfh1 mutant [27]
b For genes with a cell cycle-dependent expression [22], the stage with the greatest
expression is indicated
Asterisks indicate genes downregulated in a Dpet117-defective mutant
Genes in boldface type were not repressed by hydrogen peroxide, menadione or diamide
treatment in experiments reported in Ref. 2 and 3. Repression was only considered when at
least two consecutive time points gave significantly reduced levels under the experimental
conditions employed in these studies
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Table III
Expression of Dgrx5-repressed genes involved in mitochondrial functions under respiratory
conditions
Gene Post-diauxic phaseª Hap4 overexpressionb
COX5A +
COX6 + +
COX9 + +
COX13 +
COX17 +
CYC1 + +
CYT1 + +
NDI1 + +
QCR6 + +
QCR7 +
QCR9 +
QCR10 +
RIP1 + +
SDH4 + +
YDR316W +
YER182W +
ª Data from Ref. 11
b Data from Ref. 12
+ denotes significant induction under the experimental conditions reported
log2 (D pet117/ wild type)
Fig. 1
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